TABLE 1.
Major guidelines for psoriatic disease screening, treatment, and monitoring
| ORGANIZATION | REFERENCE | ONLINE RESOURCES |
|---|---|---|
| American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF)14,15 | Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol.2019;80(4):1029–1072. Elmets CA, Leonardi CL, Davis DMR, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073–1113. |
AAD-NPF Joint Guidelines: |
| NPF18 | Armstrong AW, Siegel MP, Bagel J, et al. From the Medical Board of the National Psoriasis Foundation: treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017;76(2):290–298. |
|
| European Academy of Dermatology and Venereology (EADV)62 | Nast A, Gisondi P, Ormerod AD, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris: update 2015, short version. EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29(12):2277–2294. | European S3 (EADV) Guidelines: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.13354 |
| European League Against Rheumatism (EULAR)63 | Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510. | Full EULAR Guidelines: http://ard.bmj.com/content/annrheumdis/75/3/499.full.pdf |
| Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)64 | Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis: treatment recommendations for psoriatic arthritis 2015. Arthritis Rheumatol. 2016;68(5):1060–1071. | Access to GRAPPA Mobile App and Psoriatic Arthritis Pocket Guide: https://psa.guidelinecentral.com |